Please login to the form below

Not currently logged in
Email:
Password:

KeyNote-158 trial

This page shows the latest KeyNote-158 trial news and features for those working in and with pharma, biotech and healthcare.

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

Merck’s Keytruda receives FDA approval for advanced endometrial cancer

The approval was based on new data from the KEYNOTE-158 trial, with 90 patients with unresectable or metastatic endometrial carcinoma being enrolled. ... Dr David O’Malley, division of gynaecologic oncology at The Ohio State University Wexner Medical

Latest news

  • More good news, and some bad, for Merck’s Keytruda More good news, and some bad, for Merck’s Keytruda

    The application is for accelerated approval based on the results of the KEYNOTE-158 trial, which showed that Keytruda, given as a monotherapy to SCLC patients whose cancer had progressed despite ... Liver failure. On the downside, Merck also revealed

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Research Partnership

Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...